Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 4/20 | 0.66 |
| ▸ | UCHL3 | P15374 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.41 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.41 |
| ▸ | AKT1 | P31749 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27752152 | 0.92 | HSD11B1 (0.73) | HSD11B1UCHL3SMN1; SMN2HPGDAVPR1A | |
| SCHEMBL195220 | 0.92 | HSD11B1 (0.73) | HSD11B1UCHL3SMN1; SMN2HPGDAVPR1A | |
| SCHEMBL23846180 | 0.92 | HSD11B1 (0.72) | HSD11B1UCHL3SMN1; SMN2HPGDAVPR1A | |
| SCHEMBL21562239 | 0.84 | HSD11B1 (0.52) | HSD11B1UCHL3SMN1; SMN2HPGDAVPR1A | |
| SCHEMBL14975277 | 0.83 | HSD11B1 (0.60) | HSD11B1UCHL3SMN1; SMN2HPGDAVPR1A | |
| SCHEMBL10111051 | 0.82 | HSD11B1 (0.63) | HSD11B1UCHL3SMN1; SMN2HPGDAVPR1A | |
| SCHEMBL17023639 | 0.81 | AVPR1A (0.59) | SMN1; SMN2HPGDAVPR1ATSHRKDM4E | |
| SCHEMBL11512580 | 0.81 | HSD11B1 (0.62) | HSD11B1HPGDPSMB5ALDH1A1HSD17B10 | |
| SCHEMBL14533545 | 0.81 | HSD11B1 (0.64) | HSD11B1UCHL3SMN1; SMN2HPGDAVPR1A | |
| SCHEMBL10035324 | 0.80 | HSD11B1 (0.60) | HSD11B1UCHL3SMN1; SMN2HPGDAVPR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11917882-B2 | Light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11917882-B2 | Light-emitting device, electronic device, and lighting device | CYBA, NR2E3, ESR1 | HSD11B1 2807/4885UCHL3 1600/4885SMN1; SMN2 4532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.